Compounds > omega-n-methylarginine
Page last updated: 2024-09-03

omega-n-methylarginine and butaclamol

omega-n-methylarginine has been researched along with butaclamol in 1 studies

Compound Research Comparison

Studies
(omega-n-methylarginine)		Trials
(omega-n-methylarginine)		Recent Studies (post-2010)
(omega-n-methylarginine)		Studies
(butaclamol)		Trials
(butaclamol)		Recent Studies (post-2010) (butaclamol)
4,4113443363308

Protein Interaction Comparison

ProteinTaxonomyomega-n-methylarginine (IC50)butaclamol (IC50)
D(2) dopamine receptorHomo sapiens (human)0.0123
DRattus norvegicus (Norway rat)0.002
D(3) dopamine receptorRattus norvegicus (Norway rat)0.002
D(1A) dopamine receptorHomo sapiens (human)0.05
D(4) dopamine receptorHomo sapiens (human)0.05
D(1B) dopamine receptorHomo sapiens (human)0.05
D(1B) dopamine receptorRattus norvegicus (Norway rat)0.002
D(4) dopamine receptorRattus norvegicus (Norway rat)0.002
D(3) dopamine receptorHomo sapiens (human)0.0139
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0053
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.0525

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X1

Other Studies

1 other study(ies) available for omega-n-methylarginine and butaclamol

ArticleYear
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
    Journal of medicinal chemistry, 2008, Jul-24, Volume: 51, Issue:14

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship

2008